Try our mobile app

General information

Country: UNITED STATES

Sector: Diagnostics and Research

Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
Website: thermofisher.com


  • Bad financial results growth rate -2.2% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (8.6%)
  • Dividend yield for the last twelve months 0.2%
  • Free cash flow yield -0.2% (LTM)
  • Share price is 37.4% higher than minimum and 11.2% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (28.2x vs
    )
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $86.7 mln (-0.038% of cap.)

Key Financials (Download financials)

Ticker: TMO
Share price, USD:  (-0.7%)592.75
year average price 531.30  


year start price 527.38 2023-05-19

min close price 431.41 2023-10-27

max close price 599.43 2024-03-11

current price 597.15 2024-05-17
Common stocks: 391 000 000

Dividend Yield:  0.2%
FCF Yield LTM: -0.2%
EV / LTM EBITDA: 28.2x
EV / EBITDA annualized: 26.5x
Last revenue growth (y/y):  -4.9%
Last growth of EBITDA (y/y):  0.6%
Historical revenue growth:  12.1%
Historical growth of EBITDA:  5.1%
Target EV / EBITDA (hist percentile):
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 231 765
Net Debt ($m): -7 967
EV (Enterprise Value): 223 798
EBITDA LTM ($m): 7 927
EV / LTM EBITDA: 28.2x
Price to Book: 5.1x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2024-05-16zacks.com

Thermo Fisher (TMO) Unveils New Extended Blood Genotyping Array

2024-05-14Seeking Alpha

Thermo Fisher Scientific Inc. (TMO) Presents at Bank of Bank of America Securities 2024 Health Care Conference (Transcript)

2024-05-06Zacks Investment Research

Don't Overlook Thermo Fisher (TMO) International Revenue Trends While Assessing the Stock

2024-04-24Zacks Investment Research

Thermo Fisher (TMO) Q1 Earnings Top Estimates, 2024 View Up

2024-04-24Zacks Investment Research

Compared to Estimates, Thermo Fisher (TMO) Q1 Earnings: A Look at Key Metrics

2024-04-24Reuters

Thermo Fisher lifts profit forecast as medical equipment demand improves

2024-04-19Zacks Investment Research

Seeking Clues to Thermo Fisher (TMO) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics

2024-04-15Zacks Investment Research

What's in Store for Thermo Fisher (TMO) in Q1 Earnings?

2024-04-09InvestorPlace

Thermo Fisher Layoffs 2024: What to Know About the Latest TMO Job Cuts

2024-04-09Zacks Investment Research

Thermo Fisher (TMO) Launches TSX Universal Series ULT Freezers
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data